ORIGINAL ARTICLE
Year : 1997 | Volume
: 45 | Issue : 3 | Page : 177--180
Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis
A Sharma, R Gupta, J Ram, A Gupta Department of Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Correspondence Address:
A Sharma Department of Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh India
The efficacy of topical ketorolac 0.5% in treatment of vernal keratoconjunctivitis (VKC) was evaluated in a randomised double-blind prospective trial in 21 patients. Ketorolac treated eyes showed 50.7% reduction in main symptoms of itching compared to 33.3% relief in placebo treated eyes after 2 weeks of treatment (p<0.01). Photophobia, ropy discharge, and conjunctival injection also lessened by 39.9%, 31.6%, and 39.1%, respectively, in ketorolac treated eyes compared to 23.8%, 17.3%, and 20.3% in placebo group. Transient stinging sensation was observed in 3 (14.3%) patients on ketorolac therapy. This study shows efficacy of ketorolac 0.5% solution in controlling symptoms in VKC.
How to cite this article:
Sharma A, Gupta R, Ram J, Gupta A. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.Indian J Ophthalmol 1997;45:177-180
|
How to cite this URL:
Sharma A, Gupta R, Ram J, Gupta A. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Indian J Ophthalmol [serial online] 1997 [cited 2024 Mar 28 ];45:177-180
Available from: https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=1997;volume=45;issue=3;spage=177;epage=180;aulast=Sharma;type=0 |
|
|